Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 19, 2017

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
InfectionHeart; Surgery, Heart, Functional Disturbance as ResultBacteremia
Interventions
DEVICE

Chlorhexidine flush

"1. For patients randomized to the CHG-LockTM device, attach a attach a BD Posiflush ™ 0.9% Sodium Chloride (Na Cl) 10ml syringe and a CHG-Lock™ device for each IV line that is to be locked. Follow hospital approved protocol for flush, volumes and hand hygiene.~ After a Catheter has been locked, before re-accessing the catheter for further sampling or infusions, all fluid should be aspirated from the catheter to clear the device of CHG, Heparin and the like. This should also confirm patency of the device.~2. Discard the syringe and device in biohazard waste.~3. Blue Cap the IV as per routine practice."

Trial Locations (1)

L8L 2X2

Hamilton Health Sciences, Hamilton

All Listed Sponsors
collaborator

Dr. Richard Whitlock

UNKNOWN

collaborator

Dr. Julian Owen

UNKNOWN

collaborator

Pamela Benoit, RN

UNKNOWN

lead

Alison Fox-Robichaud

OTHER

NCT03309137 - Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients | Biotech Hunter | Biotech Hunter